|Last Price||Today's Change||52-Week Range||Trading Volume|
|50.14||0.77 (+1.56%)||45.69 - 63.62||24.3 million (Above Avg)|
Market data as of 4:02PM 10/02/15. Quotes are delayed by at least 15 min.
FDA Approves KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression On or After Platinum-Containing Chemotherapy
10/02/2015 2:49 PM ET
International Coalition Urges Final Push to Eliminate River Blindness from the Americas
09/29/2015 10:30 AM ET